CTI BioPharma Corp.
$69 Million - Follow-OnSole Bookrunner
Seattle Genetics, Inc.
$614 Million - Acquisition of Cascadian TherapeuticsLead Financial Advisor
Alder BioPharmaceuticals, Inc.
$250 Million - Convertible Senior NotesJoint Bookrunner
AGN / Looking for Migraine Relief; A Closer Look at AGN’s Oral CGRPs
Healthcare / 2018 Outlook: Alpha Opportunities Abound in Healthcare Shares
BDX / Mgmt. Meeting Takeaways; BCR Deal Close & EPS Accretion Around the Corner